Natera (NTRA) Total Current Liabilities (2014 - 2026)
Natera's (NTRA) quarterly Total Current Liabilities came in at $553.2 million in Q2 2026, up 43.75% on a YoY basis from $384.8 million in Q2 2025, and down 0.91% quarter-over-quarter from $558.3 million in Q1 2026.
Analysis
Natera (NTRA) Total Current Liabilities (2014 - 2026) Analysis & Trends
Natera (NTRA) has reported Total Current Liabilities for 13 consecutive years, with $553.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities rose 43.75% year-over-year to $553.2 million; the trailing twelve-month figure through Jun 2026 stood at $553.2 million (up 43.75% YoY), and the FY2025 full-year result was $441.2 million, up 28.25% from the prior year.
- Total Current Liabilities retreated to $553.2 million in Q2 2026 per NTRA's latest filing, from $558.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $558.3 million in Q1 2026 and bottomed at $231.1 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $346.5 million across 5 years, with a median of $308.9 million in 2022.
- The sharpest annual moves came in 2023 and 2026: Total Current Liabilities declined 1.04% in 2023, then surged 52.66% in 2026.
- Over 5 years, Total Current Liabilities stood at $310.5 million in 2022, then decreased by 1.04% to $307.3 million in 2023, then gained by 11.97% to $344.0 million in 2024, then increased by 28.25% to $441.2 million in 2025, then advanced by 25.38% to $553.2 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $553.2 million, $558.3 million, and $441.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 553.20 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 1.79 Bn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 2.12 Bn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 338.96 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 391.49 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 191.44 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 231.24 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 55.73 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 87.71 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 196.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 553.20 Mn |
| Mar 31, 2026 | 558.26 Mn |
| Dec 31, 2025 | 441.23 Mn |
| Sep 30, 2025 | 442.02 Mn |
| Jun 30, 2025 | 384.84 Mn |
| Mar 31, 2025 | 365.68 Mn |
| Dec 31, 2024 | 344.05 Mn |
| Sep 30, 2024 | 301.42 Mn |
| Jun 30, 2024 | 314.57 Mn |
| Mar 31, 2024 | 305.95 Mn |
| Dec 31, 2023 | 307.27 Mn |
| Sep 30, 2023 | 289.92 Mn |
| Jun 30, 2023 | 276.86 Mn |
| Mar 31, 2023 | 290.97 Mn |
| Dec 31, 2022 | 310.50 Mn |
| Sep 30, 2022 | 267.28 Mn |
| Jun 30, 2022 | 251.62 Mn |
| Mar 31, 2022 | 231.07 Mn |
| Dec 31, 2021 | 218.96 Mn |
| Sep 30, 2021 | 199.71 Mn |